显影剂的全球市场:现状分析与预测(2021年～2027年)

全球显影剂的市场规模在预测期间(2021年～2027年)中预计将以约4％的年复合成长率成长。慢性病的增加、老年人口的增加、频繁的产品发布以及医疗保险覆盖面的增加正在推动造影剂市场的增长。

本报告提供全球显影剂市场的相关调查，提供市场洞察，市场趋势，竞争模式，企业概要等全面性资讯。

目录

第1章 市场简介

• 市场定义
• 限制
• 相关利益者
• 报告所使用的货币

第2章 调查方法或假设

• 显影剂市场调查流程
• 显影剂市场调查手法
• 预测方法
• 受访者简介
• 显影剂市场调查的主要目的

第3章 市场摘要

第4章 摘要整理

第5章 全球显影剂市场上COVID-19的影响

第6章 全球显影剂市场收益(2019年～2027年)

第7章 市场洞察:各种模式

• X光/CT
• MRI
• 超音波

第8章 市场洞察:各产品类型

• 碘
• 钡为基础的
• 钆为基础的
• 微泡沫

第9章 市场洞察:各用途

• 心血管疾病
• 神经疾病
• 肠胃障碍
• 癌症
• 肾障碍
• 肌肉骨骼系统障碍
• 其他

第10章 市场洞察:各终端用户

• 医院
• 影像诊断中心
• 其他

第11章 市场洞察:各地区

• 北美
  • 美国
  • 加拿大
  • 其他北美
• 欧洲
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙
  • 其他欧洲
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 其他亚太地区
• 全球其他地区

第12章 显影剂市场力学

• 推动市场要素
• 市场课题
• 影响分析

第13章 显影剂市场机会

第14章 显影剂市场趋势

第15章 法律及法律规范

第16章 需求面和供给面的分析

• 需求面分析
• 供给面分析

第17章 价值链分析

第18章 竞争模式

• 波特的五力分析

第19章 公司概要

• GE Healthcare
• Bracco Imaging SPA
• Bayer AG
• Guerbet
• Lantheus Medical Imaging, Inc.
• Unijules Life Sciences, J.B.
• Chemicals and Pharmaceuticals Ltd.
• SANOCHEMIA Pharmazeutika GmbH
• Taejoon Pharm
• Judas Expoim

第20章 免责声明

Global Contrast Media Market is anticipated to grow with an elevated CAGR of around 4% over the forecast period (2021-2027). Contrast media are a group of chemical agents developed to aid in the characterization of pathology by improving the contrast resolution of an imaging modality. Specific contrast media have been developed for every structural imaging modality and every conceivable route of administration.

The market for contrast media is witnessing growth due to the increasing prevalence of chronic diseases and the rapidly rising geriatric population. Furthermore, the frequent product launches coupled with the mergers and acquisitions have a rocketing contrast media market. For instance, in December 2021, GE announced that it has completed the acquisition of BK Medical, a leader in advanced surgical visualization, from Altaris Capital Partners, LLC. The companies entered into a definitive agreement for GE to purchase BK Medical for a cash purchase price of $1.45 billion. Moreover, the increasing number of medical insurance along with rising awareness about the serious effects of diseases significantly affect the market dynamics of the diagnostic and contrast media market.

GE Healthcare, Bracco Imaging SPA, Bayer AG, Guerbet, Lantheus Medical Imaging Inc., Unijules Life Sciences, J.B. Chemicals and Pharmaceuticals Ltd., SANOCHEMIA Pharmazeutika GmbH, Taejoon Pharm, and Judas Expoim are some of the prominent players operating in the Contrast Media market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with new varieties of Contrast Media devices.

Insights Presented in the Report

"Amongst Modality, X-ray/CT segment holds the major share"

Based on modality, the market is categorized into X-ray/CT, MRI, and Ultrasound. The X-ray/CT segment had a significant market share in 2020 and is anticipated to witness significant growth during the forecast period. This is mainly due to the availability of more advanced CT scans which provides detailed 3D images of soft tissues as well as bones. Furthermore, the increasing prevalence of pulmonary diseases is a contributing factor to the growth of the segment in the contrast media market. For instance, as per the WHO, Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide, causing 3.23 million deaths in 2019 and around 90% of COPD deaths in those under 70 years of age occur in low- and middle-income countries.

"Amongst Product Type, microbubble segment holds the major share"

Based on product type, the market is segmented into iodinated, barium-based, gadolinium-based, and microbubble. The iodinated segment grabbed a significant market share in 2020. The iodinated media is extensively used in the diagnosis of the blockage of the blood vessels and to detect urinary tract infections. However, the microbubble segment is anticipated to grow at a considerable pace during the forecast period. This is mainly due to the advantage offered by the techniques such as being easily digestible in the liver. Furthermore, the increasing incidents of cardiovascular diseases and their treatments such as angioplasty contribute to the growth of the microbubble market during the forecast period. For instance, as per CDC, Every year, about 805,000 people in the United States have a heart attack. Among them, 605,000 are a first heart attack 200,000 happen to people who have already had a heart attack.

"Amongst Application, neurological disorder segment holds the major share"

Based on application, the market is fragmented into cardiovascular disorders, neurological disorders, gastrointestinal disorders, cancer, nephrological disorders, musculoskeletal disorders, and others. Neurological disorder is expected to grab significant market share in the contrast media market. The rising geriatric population is one of the major reasons for the rising neurological disorders. Such as Parkinson's disorders and Alzheimer's disease. For instance, according to CDC, In 2020, an estimated 5.8 million Americans aged 65 years or older had Alzheimer's disease.1 This number is projected to nearly triple to 14 million people by 2060.

"Amongst End-users, diagnostic imaging centers segment holds the major share"

Based on end-user, the market is segmented into hospitals, diagnostic imaging centers, and others. The diagnostic imaging centers are predicted to have considerable market growth during the forecast period. The segmental growth is due to the specialization of the diagnostic centers in the visualization and diagnosis along with the presence of skilled staff. Furthermore, the integration of advanced technology such as AI-based equipment and electronic patient records attributes to the growth of diagnostic imaging centers in contrast media market. For instance, Mahajan Imaging has launched an integrated center of excellence in diagnostics in Delhi to offer precision and personalized treatment to patients. The new center is equipped with an R&D department and an AI startup.

"North America represents one of the largest markets of Contrast Media market"

For a better understanding of the market dynamics of the contrast media market, a detailed analysis was conducted for different regions across the globe including North America (U.S, Canada, and the Rest of North America), Europe (Germany, France, Spain, United Kingdom, Italy, and Rest of Europe), Asia-Pacific (China, India, Australia, Japan, and Rest of APAC), Rest of World has been conducted. In 2020, North America dominated the Contrast Media industry. This can be mainly due to the major factors such as favorable government initiatives, sophisticated healthcare infrastructure, the presence of a large geriatric population, and the rise in chronic disease incidences across the region are propelling the growth of this market. For instance, the number of Americans aged 60 and older increased by 34% from 55.7 million to 74.6 million between 2009 and 2019. Also, 133 million Americans i.e., 45% of the population have at least one chronic disease. In addition to this, Chronic diseases are responsible for seven out of every 10 deaths in the U.S., killing more than 1.7 million Americans every year.

Reasons to buy this report:

• The study includes market sizing and forecasting analysis validated by authenticated key industry experts

• The report presents a quick review of overall industry performance at one glance

• The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments

• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry

• The study comprehensively covers the market across different segments

• Deep dive regional level analysis of the industry

Customization Options:

The global contrast media market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

• 1.1. Market Definitions
• 1.2. Limitation
• 1.3. Stakeholders
• 1.4. Currency used in Report

2 RESEARCH METHODOLOGY OR ASSUMPTION

• 2.1. Research Process of the Contrast Media Market
• 2.2. Research Methodology of the Contrast Media Market
• 2.3. Forecasting Method
• 2.4. Respondent Profile
• 2.5. Main Objective of the Contrast Media Market Study

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 GLOBAL CONTRAST MEDIA MARKET COVID-19 IMPACT

6 GLOBAL CONTRAST MEDIA MARKET REVENUE, 2019-2027F

7 MARKET INSIGHTS BY MODALITY

• 7.1. X-ray/CT
• 7.2. MRI
• 7.3. Ultrasound

8 MARKET INSIGHTS BY PRODUCT TYPE

• 8.1. Iodinated
• 8.2. Barium-based
• 8.3. Gadolinium-based
• 8.4. Microbubble

9 MARKET INSIGHTS BY APPLICATION

• 9.1. Cardiovascular Disorders
• 9.2. Neurological Disorders
• 9.3. Gastrointestinal Disorders
• 9.4. Cancer
• 9.5. Nephrological Disorders
• 9.6. Musculoskeletal Disorders
• 9.7. Others

10 MARKET INSIGHTS BY END-USERS

• 10.1. Hospital
• 10.2. Diagnostic Imaging Centers
• 10.3. Others

11 MARKET INSIGHTS BY REGION

• 11.1. North America
  • 11.1.1. United States
  • 11.1.2. Canada
  • 11.1.3. Rest of North America
• 11.2. Europe
  • 11.2.1. Germany
  • 11.2.2. France
  • 11.2.3. U.K.
  • 11.2.4. Italy
  • 11.2.5. Spain
  • 11.2.6. Rest of Europe
• 11.3. Asia Pacific
  • 11.3.1. China
  • 11.3.2. Japan
  • 11.3.3. India
  • 11.3.4. Australia
  • 11.3.5. Rest of Asia Pacific
• 11.4. Rest of World

12 CONTRAST MEDIA MARKET DYNAMICS

• 12.1. Market Drivers
• 12.2. Market Challenges
• 12.3. Impact Analysis

13 CONTRAST MEDIA MARKET OPPORTUNITIES

14 CONTRAST MEDIA MARKET TRENDS

15 LEGAL & REGULATORY FRAMEWORK

16 DEMAND AND SUPPLY-SIDE ANALYSIS

• 16.1. Demand Side Analysis
• 16.2. Supply Side Analysis

17 VALUE CHAIN ANALYSIS

18 COMPETITIVE SCENARIO

• 18.1. Porter's Five Forces Analysis

19 COMPANY PROFILED

• 19.1. GE Healthcare
• 19.2. Bracco Imaging SPA
• 19.3. Bayer AG
• 19.4. Guerbet
• 19.5. Lantheus Medical Imaging, Inc.
• 19.6. Unijules Life Sciences, J.B.
• 19.7. Chemicals and Pharmaceuticals Ltd.
• 19.8. SANOCHEMIA Pharmazeutika GmbH
• 19.9. Taejoon Pharm
• 19.10. Judas Expoim

20 DISCLAIMER